Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving <5 years after baseline right-sided cardiac catheterization

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1514-1520

  Batal, Omar ^a   Khatib, Omar F ^a   Dweik, Raed A ^a   Hammel, Jeffrey P ^a   McCarthy, Kevin ^a   Minai, Omar A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; PROSTACYCLIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REGRESSION ANALYSIS; SCLERODERMA; SURVIVAL; WORLD HEALTH ORGANIZATION;

ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; OHIO; PROGNOSIS; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS;

EID: 84860487840     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.366     Document Type: Article

References (29)

1. G.E. D'Alonso, R.J. Barst, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, K.M. Detre, A.P. Fishman, R.M. Goldring, B.M. Groves, J.T. Kernis, P.S. Levy, G.G. Pietra, L.M. Reid, J.T. Reeves, S. Rich, C.E. Vreim, G.W. Williams, M. Wu Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Intern Med 115 1991 343 349
2. V.V. McLaughlin, A. Shillington, S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
3. O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia, P. Hervé, M. Rainisio, G. Simonneau Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival J Am Coll Cardiol 40 2002 780 788
4. T.C. Yeo, K.S. Dujardin, C. Tei, D.W. Mahoney, M.D. McGoon, J.B. Seward Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension Am J Cardiol 81 1998 1157 1161
5. R.J. Raymond, A.L. Hinderliter, P.W. Willis, D. Ralph, E.J. Caldwell, W. Williams, N.A. Ettinger, W.R. Summer, B. de Boisblanc, T. Schwartz, G. Koch, L.M. Clayton, M.M. Jobsis, J.W. Crow, W. Long, W. Long Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension J Am Coll Cardiol 39 2002 1214 1219
6. N. Nagaya, T. Nishikimi, M. Uematsu, T. Satoh, S. Kyotani, F. Sakamaki, M. Kakishita, K. Fukushima, Y. Okano, N. Nakanishi, K. Miyatake, K. Kangawa Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension Circulation 102 2000 865 870
7. R.L. Benza, D.P. Miller, M. Gomberg-Maitland, R.P. Frantz, A.J. Foreman, C.S. Coffey, A. Frost, R.J. Barst, D.B. Badesch, C.G. Elliott, T.G. Liou, M.D. McGoon Predicting survival in pulmonary arterial hypertension insights from the Registry to EValuate Early and Long-term pulmonary arterial hypertension disease management (REVEAL) Circulation 122 2010 164 172
8. T. Thenappan, S.J. Shah, S. Rich, L. Tian, S.L. Archer, M. Gomberg-Maitland Contemporary survival in patients with pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Eur Respir J 35 2009 1079 1087
9. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, R. Souza Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
10. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi, J. Wanger ATS/ERS Task Force Standardization of lung function testing Eur Respir J 26 2005 319 338
11. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement guidelines for the six-minute walk test Am J Respir Crit Care Med 166 2002 111 117
12. S.M. Kawut, D.B. Taichman, C.L. Archer-Chicko, H.L. Palevsky, S.E. Kimmel Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis Chest 123 2003 344 350
13. V.V. McLaughlin, K.W. Presberg, R.L. Doyle, S.H. Abman, D.C. McCrory, T. Fortin, G. Ahearn American College of Chest Physicians Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 2004 78S 92S
14. S. Miyamoto, N. Nagaya, T. Satoh, S. Kyotani, F. Sakamaki, M. Fujita, N. Nakanishi, K. Miyatake Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing Am J Respir Crit Care Med 161 2000 487 492
15. C.J. Lettieri, S.D. Nathan, R.F. Browning, S.D. Barnett, S. Ahmad, A.F. Shorr The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis Respir Med 100 2006 1734 1741
16. L.B. Daniels, A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
17. P.R. Forfia, S.C. Mathaiz, M.R. Fishers, T. Housten-Harris, A.R. Hemnes, H.C. Champion, R.E. Girgis, P.M. Hassoun Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension Am J Respir Crit Care Med 177 2008 1364 1369
18. S.J. Shah, T. Thenappan, S. Rich, L. Tian, S.L. Archer, M. Gomberg-Maitland Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension Circulation 117 2008 2475 2483
19. K.P. Kuhn, D.W. Byrne, P.G. Arbogast, T.P. Doyle, J.E. Loyd, I.M. Robbins Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol Am J Respir Crit Care Med 167 2003 580 586
20. R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, B.M. Groves, V.F. Tapson, R.C. Bourge, B.H. Brundage, S.K. Koerner, D. Langleben, C.A. Keller, S. Murali, B.F. Uretsky, L.M. Clayton, M.M. Jöbsis, S.D. Blackburn, D. Shortino, J.W. Crow A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension The Primary Pulmonary Hypertension Study Group N Engl J Med 334 1996 296 302
21. G. Paciocco, F.J. Martinez, E. Bossone, E. Pielsticker, B. Gillespie, M. Rubenfire Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension Eur Respir J 17 2001 647 652
22. S. Velez Roa, A. Ciarka, B. Najem, J.L. Vachiery, R. Naeije, P. van de Borne Increased sympathetic nerve activity in primary pulmonary artery hypertension Circulation 110 2004 1308 1312
23. R. Naeije, P. van de Borne Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension Eur Respir J 34 2009 792 794
24. S. Pamidi, S. Mehta Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts? J Rheumatol 36 2009 216 218
25. Y. Schoindre, C. Meune, A.T. Dinh-Xuan, J. Avouac, A. Kahan, Y. Allanore Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis J Rheumatol 36 2009 1481 1485
26. H.H. Leuchte, M. El Nounou, J.C. Tuerpe, B. Hartmann, R.A. Baumgartner, M. Vogeser, O. Muehling, J. Behr N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension Chest 131 2007 402 409
27. S.B. Eysmann, H.I. Palevsky, N. Reichek, K. Hackney, P.S. Douglas Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension Circulation 80 1989 353 360
28. S.C. Mathai, M. Bueso, L.K. Hummers, D. Boyce, N. Lechtzin, J. Le Pavec, A. Campo, H.C. Champion, T. Housten, P.R. Forfia, A.L. Zaiman, F.M. Wigley, R.E. Girgis, P.M. Hassoun Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Eur Respir J 35 2010 95 104
29. V.V. McLaughlin, O. Sitbon, D.B. Badesch, R.J. Barst, C. Black, N. Galiè, M. Rainisio, G. Simonneau, L.J. Rubin Survival with first-line bosentan in patients with primary pulmonary hypertension Eur Respir J 25 2005 244 249